Twitxy Saved

Wayne Batchelor, MD

Verified account This account is verified. Learn more

@_WayneBatchelor

Director, Interventional Cardiology, Inova Health System. Co-Chair STS/ACC TVT Registry. Chair, ACC Interventional Council, Adj. Prof Medicine, Duke University.
Falls Church, VA Joined October 2017
153 Following 1.2K Followers 142 Posts

Latest posts 5

Wayne Batchelor, MD Verified account @_WayneBatchelor
Thrilled to share that I’ve completed my Executive MBA from @NYUStern School of Business! This incredible 2-year journey at one of the nation’s top business schools has been a transformative experience. A huge thank you to my family for their unwavering support. Grateful also to NYU Stern's faculty, administrative team, and my DC '24 EMBA classmates for their invaluable lessons and friendships. Special thanks to my mentor, @coconnormd and colleagues at Inova Schar Heart and Vascular (@ISHVnews) including @DrDamluji who convinced me to go with NYU (spot on!). Finally, I am grateful for Dr. Stephen Jones and the @InovaHealth System's Executive team for fostering a nurturing work environment that encourages growth and learning. The challenges of interventional cardiology, innovation, research, and education have always motivated me. The NYU Stern EMBA enhances my business acumen and leadership skills in ways that are hard to measure. Looking forward to the exciting opportunities that lie ahead!
22 replies 3 reposts 108 likes 7.1K views View on X
Wayne Batchelor, MD Verified account @_WayneBatchelor
Proud to Co-Chair this year's American College of Cardiology Clinical Trials Research (CTR) training program: Upping Your Game! with Pamela Douglas, Minnow Walsh, Melvin Echols, and Tracy Wang. Many thanks to our esteemed faculty and industry sponsor Medtronic. Time now to turn this work into action!
@pamelasdouglas
@ShashankSinhaMD
@MelvinEchols9
@MinnowWalsh
@MCoylewright
@EldrinL @Drroxmehran @TYWangMD
@PopmaJeffrey @ACCinTouch @Medtronic @InovaHealth @ISHVnews
5 replies 9 reposts 89 likes 7.4K views View on X
Wayne Batchelor, MD Verified account @_WayneBatchelor
Yesterday, the FDA panel voted in favor of transcatheter tricuspid repair using Abbott's Triclip device to treat severe tricuspid valve regurgitation (TR). This, in concert with the recent approval of Edwards' Evoque transcatheter valve replacement system, advances the field forward significantly and provides much needed hope for the 1.6 million people suffering from TR. Much more work to do, but very good news for patients!